SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024168
Filing Date
2022-11-10
Accepted
2022-11-10 07:41:47
Documents
57
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q caba-20220930.htm   iXBRL 10-Q 3182414
2 EX-10.1 caba-ex10_1.htm EX-10.1 779733
3 EX-31.1 caba-ex31_1.htm EX-31.1 22844
4 EX-31.2 caba-ex31_2.htm EX-31.2 22821
5 EX-32.1 caba-ex32_1.htm EX-32.1 13473
6 EX-32.2 caba-ex32_2.htm EX-32.2 14030
  Complete submission text file 0000950170-22-024168.txt   9813906

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT caba-20220930_cal.xml EX-101.CAL 32683
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT caba-20220930_pre.xml EX-101.PRE 234320
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT caba-20220930.xsd EX-101.SCH 37214
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT caba-20220930_lab.xml EX-101.LAB 328835
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT caba-20220930_def.xml EX-101.DEF 137703
51 EXTRACTED XBRL INSTANCE DOCUMENT caba-20220930_htm.xml XML 1730213
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39103 | Film No.: 221374982
SIC: 2836 Biological Products, (No Diagnostic Substances)